Nevertheless, we did not find significant changes in mTORC1 activation upon autophagy blockade by FIP200 deletion, suggesting that it is unlikely that autophagy inhibition abrogated LM progression to LAS by directly affecting mTORC1 as a driver in vascular tumor cells. This evidence concerns the gene RB1CC1 and vascular neoplasm.